Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2023 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac...
Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
March 16, 2023 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., March 16, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac...
Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2023 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac...
Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter
February 06, 2023 06:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 01, 2023 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer
January 09, 2023 06:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 03, 2023 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
December 29, 2022 06:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic
December 21, 2022 06:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...